Press Releases Year All News | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | Apr 29, 2021 TCR² Therapeutics to Present at the Truist Securities Life Sciences Summit Apr 10, 2021 TCR² Highlights Gavo-cel Translational Data and Emerging Solid Tumor Pipeline Preclinical Data at AACR Annual Meeting Apr 08, 2021 TCR² Therapeutics to Present at the Needham Healthcare Conference Mar 29, 2021 TCR² Therapeutics Establishes Commercial-Scale Cell Therapy Manufacturing Facility Mar 11, 2021 TCR² Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update Mar 10, 2021 TCR² Presentations at American Association of Cancer Research (AACR) Annual Meeting 2021 to Highlight Solid Tumor Pipeline Mar 03, 2021 TCR² Therapeutics to Participate in Two Upcoming Conferences in March Feb 17, 2021 TCR² Therapeutics to Present at SVB Leerink Global Healthcare Conference Feb 04, 2021 TCR² Therapeutics Announces Commercial Cell Therapy Leader Shawn Tomasello Joins its Board of Directors Jan 19, 2021 TCR² Therapeutics Announces Pricing of Public Offering of $140.0 Million of Common Stock Pagination First page « first Previous page ‹ previous Page 1 Current page 2 Page 3 Next page next › Last page last »
